Sponsor: American Psychiatric Association
|Presenter: Kathleen Brady, MD, PhD, Distinguished Professor, Medical University of South Carolina|
About the webinar: Exacerbated by the COVID-19 pandemic, the opioid epidemic in the United States is a dangerous reality that affects all demographics. In this presentation, gender differences in opioid use disorders will be discussed from an epidemiologic perspective. Understanding the differences in trends by gender can help clinicians treat the patient, rather than treating the condition. Neurobiological and social determinants will also be reviewed as the differences vary greatly by gender. Finally, treatment implications will be discussed so we can better understand the impact of tailored OUD treatment.
Educational objectives: At the conclusion of this activity participants should be able to:
- Apply the epidemiologic differences in the prevalence of OUD to your practice setting.
- Identify the gender differences in neurobiology of OUD when treating patients.
- Evaluate the patient treatment outcomes based on gender.
To register click here
Target audience: Interprofessional teams, psychiatrists, physicians, nurses, physician assistants. The live webinar is accredited for physicians.
This is an open ended event
- no fee